These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
186 related items for PubMed ID: 6319885
1. Comparison of mu-, delta- and kappa-receptor binding sites through pharmacologic evaluation of p-nitrophenylalanine analogs of opioid peptides. Schiller PW, Nguyen TM, DiMaio J, Lemieux C. Life Sci; 1983; 33 Suppl 1():319-22. PubMed ID: 6319885 [Abstract] [Full Text] [Related]
2. Antinociceptive potencies of beta-casomorphin analogs as compared to their affinities towards mu and delta opiate receptor sites in brain and periphery. Brantl V, Pfeiffer A, Herz A, Henschen A, Lottspeich F. Peptides; 1982; 3(5):793-7. PubMed ID: 6294635 [Abstract] [Full Text] [Related]
3. Interaction of p-nitrophenylalanine enkephalins with mu-, delta- and kappa-subtypes of the opiate receptor. Fauchère JL, Do KQ, Schwyzer R, Robson LE, Gillan MG, Paterson SJ, Kosterlitz HW. Eur J Pharmacol; 1982 Feb 05; 77(4):339-42. PubMed ID: 6277677 [Abstract] [Full Text] [Related]
4. Receptors for opioid peptides in the guinea-pig ileum. Takemori AE, Portoghese PS. J Pharmacol Exp Ther; 1985 Nov 05; 235(2):389-92. PubMed ID: 2997432 [Abstract] [Full Text] [Related]
5. Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moiety. Ananthan S, Johnson CA, Carter RL, Clayton SD, Rice KC, Xu H, Davis P, Porreca F, Rothman RB. J Med Chem; 1998 Jul 16; 41(15):2872-81. PubMed ID: 9667975 [Abstract] [Full Text] [Related]
6. Development of a model for the delta opioid receptor pharmacophore. 2. Conformationally restricted Phe3 replacements in the cyclic delta receptor selective tetrapeptide Tyr-c[D-Cys-Phe-D-Pen]OH (JOM-13). Mosberg HI, Omnaas JR, Lomize A, Heyl DL, Nordan I, Mousigian C, Davis P, Porreca F. J Med Chem; 1994 Dec 09; 37(25):4384-91. PubMed ID: 7996550 [Abstract] [Full Text] [Related]
8. A novel cyclic opioid peptide analog showing high preference for mu-receptors. Schiller PW, Nguyen TM, Maziak L, Lemieux C. Biochem Biophys Res Commun; 1985 Mar 15; 127(2):558-64. PubMed ID: 2983726 [Abstract] [Full Text] [Related]
9. Pseudoproline-containing analogues of morphiceptin and endomorphin-2: evidence for a cis Tyr-Pro amide bond in the bioactive conformation. Keller M, Boissard C, Patiny L, Chung NN, Lemieux C, Mutter M, Schiller PW. J Med Chem; 2001 Nov 08; 44(23):3896-903. PubMed ID: 11689075 [Abstract] [Full Text] [Related]
10. Conversion of delta-, kappa- and mu-receptor selective opioid peptide agonists into delta-, kappa- and mu-selective antagonists. Schiller PW, Weltrowska G, Nguyen TM, Lemieux C, Chung NN, Lu Y. Life Sci; 2003 Jun 27; 73(6):691-8. PubMed ID: 12801590 [Abstract] [Full Text] [Related]
11. Potent morphiceptin analogs: structure activity relationships and morphine-like activities. Chang KJ, Wei ET, Killian A, Chang JK. J Pharmacol Exp Ther; 1983 Nov 27; 227(2):403-8. PubMed ID: 6313901 [Abstract] [Full Text] [Related]
12. Synthesis and activity profiles of novel cyclic opioid peptide monomers and dimers. Schiller PW, Nguyen TM, Lemieux C, Maziak LA. J Med Chem; 1985 Dec 27; 28(12):1766-71. PubMed ID: 2999401 [Abstract] [Full Text] [Related]
13. Opioid receptor selectivity of beta-endorphin in vitro and in vivo: mu, delta and epsilon receptors. Shook JE, Kazmierski W, Wire WS, Lemcke PK, Hruby VJ, Burks TF. J Pharmacol Exp Ther; 1988 Sep 27; 246(3):1018-25. PubMed ID: 2843623 [Abstract] [Full Text] [Related]
14. Cyclic beta-casomorphin analogues with mixed mu agonist/delta antagonist properties: synthesis, pharmacological characterization, and conformational aspects. Schmidt R, Vogel D, Mrestani-Klaus C, Brandt W, Neubert K, Chung NN, Lemieux C, Schiller PW. J Med Chem; 1994 Apr 15; 37(8):1136-44. PubMed ID: 8164255 [Abstract] [Full Text] [Related]
15. Pharmacologic evaluation of a cyclic somatostatin analog with antagonist activity at mu opioid receptors in vitro. Shook JE, Pelton JT, Wire WS, Hirning LD, Hruby VJ, Burks TF. J Pharmacol Exp Ther; 1987 Mar 15; 240(3):772-7. PubMed ID: 2882015 [Abstract] [Full Text] [Related]
16. Conformational restriction of the phenylalanine residue in a cyclic opioid peptide analogue: effects on receptor selectivity and stereospecificity. Schiller PW, Weltrowska G, Nguyen TM, Lemieux C, Chung NN, Marsden BJ, Wilkes BC. J Med Chem; 1991 Oct 15; 34(10):3125-32. PubMed ID: 1656045 [Abstract] [Full Text] [Related]
17. Selectivities of opioid peptide analogues as agonists and antagonists at the delta-receptor. Corbett AD, Gillan MG, Kosterlitz HW, McKnight AT, Paterson SJ, Robson LE. Br J Pharmacol; 1984 Sep 15; 83(1):271-9. PubMed ID: 6091824 [Abstract] [Full Text] [Related]
19. Opioid activity of dermenkephalin analogues in the guinea-pig myenteric plexus and the hamster vas deferens. Sagan S, Corbett AD, Amiche M, Delfour A, Nicolas P, Kosterlitz HW. Br J Pharmacol; 1991 Oct 13; 104(2):428-32. PubMed ID: 1665735 [Abstract] [Full Text] [Related]
20. Effect of aromatic amino acid substitutions in the 3-position of cyclic beta-casomorphin analogues on mu-opioid agonist/delta-opioid antagonist properties. Schmidt R, Wilkes BC, Chung NN, Lemieux C, Schiller PW. Int J Pept Protein Res; 1996 Nov 13; 48(5):411-9. PubMed ID: 8956074 [Abstract] [Full Text] [Related] Page: [Next] [New Search]